Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
Top Cited Papers
Open Access
- 31 July 2008
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 135 (1), 100-110
- https://doi.org/10.1053/j.gastro.2008.03.078
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Long-term follow-up of patients with NAFLD and elevated liver enzymesJournal of Hepatology, 2006
- Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis CJournal of Hepatology, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisJournal of Hepatology, 2006
- Effect of changes on body weight and lifestyle in nonalcoholic fatty liver diseaseJournal of Hepatology, 2005
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyGastroenterology, 2005
- NASH: a hidden and silent fibroser finally revealed?Journal of Hepatology, 2005
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeJournal of Hepatology, 2003
- Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinomaGastroenterology, 2002
- Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosisJournal of Hepatology, 2002
- Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalitiesGastroenterology, 2001